Study of the contribution of active defense mechanisms to ciprofloxacin tolerance in Escherichia coli growing at different rates

Antonie Van Leeuwenhoek. 2022 Feb;115(2):233-251. doi: 10.1007/s10482-021-01693-6. Epub 2022 Jan 13.

Abstract

Using rpoS, tolC, ompF, and recA knockouts, we investigated their effect on the physiological response and lethality of ciprofloxacin in E. coli growing at different rates on glucose, succinate or acetate. We have shown that, regardless of the strain, the degree of changes in respiration, membrane potential, NAD+/NADH ratio, ATP and glutathione (GSH) strongly depends on the initial growth rate and the degree of its inhibition. The deletion of the regulator of the general stress response RpoS, although it influenced the expression of antioxidant genes, did not significantly affect the tolerance to ciprofloxacin at all growth rates. The mutant lacking TolC, which is a component of many E. coli efflux pumps, showed the same sensitivity to ciprofloxacin as the parent. The absence of porin OmpF slowed down the entry of ciprofloxacin into cells, prolonged growth and shifted the optimal bactericidal concentration towards higher values. Deficiency of RecA, a regulator of the SOS response, dramatically altered the late phase of the SOS response (SOS-dependent cell death), preventing respiratory inhibition and a drop in membrane potential. The recA mutation inverted GSH fluxes across the membrane and abolished ciprofloxacin-induced H2S production. All studied mutants showed an inverse linear relationship between logCFU ml-1 and the specific growth rate. Mutations shifted the plot of this dependence relative to the parental strain according to their significance for ciprofloxacin tolerance. The crucial role of the SOS system is confirmed by dramatic shift down of this plot in the recA mutant.

Keywords: Ciprofloxacin; Glutathione; Hydrogen sulfide; Membrane potential; Respiration; Specific growth rate; ompF, rpoS, tolC and recA knockouts.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Ciprofloxacin* / pharmacology
  • Defense Mechanisms
  • Escherichia coli / genetics
  • Escherichia coli Proteins* / genetics
  • Mutation

Substances

  • Anti-Bacterial Agents
  • Escherichia coli Proteins
  • Ciprofloxacin